Deals
Switzerland's Unilabs Said to Draw Sonic, Cinven, PAI Interest
- Sale of diagnostics provider also attracts Denmark's Novo
- Geneva-based Unilabs could fetch as much as 1.5 billion euros
This article is for subscribers only.
The sale of Swiss diagnostics company Unilabs SA has drawn interest from companies including Australia’s biggest listed medical-test provider, Sonic Healthcare Ltd., and buyout firms such as Cinven, people familiar with the matter said.
Unilabs has also attracted Novo A/S, the Danish holding company that’s the biggest shareholder of insulin maker Novo Nordisk A/S, and private-equity firm PAI Partners SAS as potential suitors, according to the people. They asked not to be identified as the information is private.